REDC Product Development and Cf Program

Nuclear Medicine Program

Medical Collaborative Programs, Technology Transfer Efforts and Clinical Evaluation of ORNL Radiopharmaceuticals

Collaboration with external organizations and technology transfer are important activities that bridge the gap between development and testing of new agents developed at ORNL and use at other institutions.  Several patents have recently been issued for new technologies developed at ORNL.  Various new agents are evaluated in collaborative programs with Medical Cooperative Programs at clinics, universities, and other research institutions in the United States, Europe, Australia and Asia.